Average Co-Inventor Count = 6.44
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Astex Therapeutics Limited (5 from 123 patents)
2. Glaxosmithkline Intellectual Property Development Limited (4 from 230 patents)
3. Convergence Pharmaceuticals Limited (4 from 24 patents)
4. Otsuka Pharmaceutical Company, Limited (3 from 846 patents)
5. Glaxo Group Limited (2 from 1,168 patents)
6. Calchan Limited (1 from 1 patent)
15 patents:
1. 11939321 - Benzolactam compounds as protein kinase inhibitors
2. 11001575 - Benzolactam compounds as protein kinase inhibitors
3. 10604509 - Nrf2 regulators
4. 10457669 - Benzolactam compounds as protein kinase inhibitors
5. 10364256 - Biaryl pyrazoles as NRF2 regulators
6. 10351530 - Arylcyclohexyl pyrazoles as NRF2 regulators
7. 10144731 - Nrf2 regulators
8. 9585886 - ASK1 inhibiting pyrrolopyrimidine derivatives
9. 9145354 - Pharmaceutical compounds
10. 9045485 - ASK 1 inhibiting pyrrolopyrimidine derivatives
11. 8933132 - Tricyclic substituted benzenesulfonamide piperazine derivatives as CAV2.2 calcium channel blockers
12. 8697703 - [object Object]
13. 8324254 - Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (S1P) agonists
14. 8101775 - Indole derivatives as S1P1 Receptor
15. 8093249 - Pyrazolo[1,5-A]pyrimidine-carbonyl-piperazine derivatives